Literature DB >> 20798673

Dop functions as a depupylase in the prokaryotic ubiquitin-like modification pathway.

Frank Imkamp1, Frank Striebel, Markus Sutter, Dennis Ozcelik, Natalie Zimmermann, Peter Sander, Eilika Weber-Ban.   

Abstract

Post-translational modification of proteins with prokaryotic ubiquitin-like protein (Pup) is the bacterial equivalent of ubiquitination in eukaryotes. Mycobacterial pupylation is a two-step process in which the carboxy-terminal glutamine of Pup is first deamidated by Dop (deamidase of Pup) before ligation of the generated γ-carboxylate to substrate lysines by the Pup ligase PafA. In this study, we identify a new feature of the pupylation system by demonstrating that Dop also acts as a depupylase in the Pup proteasome system in vivo and in vitro. Dop removes Pup from substrates by specific cleavage of the isopeptide bond. Depupylation can be enhanced by the unfolding activity of the mycobacterial proteasomal ATPase Mpa.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20798673      PMCID: PMC2948181          DOI: 10.1038/embor.2010.119

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  16 in total

1.  Prokaryotic ubiquitin-like protein provides a two-part degron to Mycobacterium proteasome substrates.

Authors:  Kristin E Burns; Michael J Pearce; K Heran Darwin
Journal:  J Bacteriol       Date:  2010-03-16       Impact factor: 3.490

2.  Bacterial ubiquitin-like modifier Pup is deamidated and conjugated to substrates by distinct but homologous enzymes.

Authors:  Frank Striebel; Frank Imkamp; Markus Sutter; Martina Steiner; Azad Mamedov; Eilika Weber-Ban
Journal:  Nat Struct Mol Biol       Date:  2009-05-17       Impact factor: 15.369

Review 3.  Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.

Authors:  Francisca E Reyes-Turcu; Karen H Ventii; Keith D Wilkinson
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

4.  Proteasomal protein degradation in Mycobacteria is dependent upon a prokaryotic ubiquitin-like protein.

Authors:  Kristin E Burns; Wei-Ting Liu; Helena I M Boshoff; Pieter C Dorrestein; Clifton E Barry
Journal:  J Biol Chem       Date:  2008-11-21       Impact factor: 5.157

Review 5.  DUBs at a glance.

Authors:  Keith D Wilkinson
Journal:  J Cell Sci       Date:  2009-07-15       Impact factor: 5.285

6.  rpsL+: a dominant selectable marker for gene replacement in mycobacteria.

Authors:  P Sander; A Meier; E C Böttger
Journal:  Mol Microbiol       Date:  1995-06       Impact factor: 3.501

7.  Identification of substrates of the Mycobacterium tuberculosis proteasome.

Authors:  Michael J Pearce; Pooja Arora; Richard A Festa; Susan M Butler-Wu; Rajesh S Gokhale; K Heran Darwin
Journal:  EMBO J       Date:  2006-11-02       Impact factor: 11.598

Review 8.  Recognition and processing of ubiquitin-protein conjugates by the proteasome.

Authors:  Daniel Finley
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  Ubiquitin-like protein involved in the proteasome pathway of Mycobacterium tuberculosis.

Authors:  Michael J Pearce; Julian Mintseris; Jessica Ferreyra; Steven P Gygi; K Heran Darwin
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

10.  Unraveling the biochemistry and provenance of pupylation: a prokaryotic analog of ubiquitination.

Authors:  Lakshminarayan M Iyer; A M Burroughs; L Aravind
Journal:  Biol Direct       Date:  2008-11-03       Impact factor: 4.540

View more
  44 in total

Review 1.  Trojan horse strategies used by pathogens to influence the small ubiquitin-like modifier (SUMO) system of host eukaryotic cells.

Authors:  Miklós Békés; Marcin Drag
Journal:  J Innate Immun       Date:  2012-01-03       Impact factor: 7.349

2.  A further case of Dop-ing in bacterial pupylation.

Authors:  Anja Bremm; David Komander
Journal:  EMBO Rep       Date:  2010-09-17       Impact factor: 8.807

3.  Proteasomal control of cytokinin synthesis protects Mycobacterium tuberculosis against nitric oxide.

Authors:  Marie I Samanovic; Shengjiang Tu; Ondřej Novák; Lakshminarayan M Iyer; Fiona E McAllister; L Aravind; Steven P Gygi; Stevan R Hubbard; Miroslav Strnad; K Heran Darwin
Journal:  Mol Cell       Date:  2015-02-26       Impact factor: 17.970

Review 4.  Bacterial Proteasomes: Mechanistic and Functional Insights.

Authors:  Samuel H Becker; K Heran Darwin
Journal:  Microbiol Mol Biol Rev       Date:  2016-12-14       Impact factor: 11.056

5.  Reconstitution of the Mycobacterium tuberculosis pupylation pathway in Escherichia coli.

Authors:  Francisca A Cerda-Maira; Fiona McAllister; Nadine J Bode; Kristin E Burns; Steven P Gygi; K Heran Darwin
Journal:  EMBO Rep       Date:  2011-07-08       Impact factor: 8.807

6.  Mycobacterium tuberculosis prokaryotic ubiquitin-like protein-deconjugating enzyme is an unusual aspartate amidase.

Authors:  Kristin E Burns; Fiona E McAllister; Carsten Schwerdtfeger; Julian Mintseris; Francisca Cerda-Maira; Elke E Noens; Matthias Wilmanns; Stevan R Hubbard; Francesco Melandri; Huib Ovaa; Steven P Gygi; K Heran Darwin
Journal:  J Biol Chem       Date:  2012-08-31       Impact factor: 5.157

7.  Posttranslational regulation of coordinated enzyme activities in the Pup-proteasome system.

Authors:  Yifat Elharar; Ziv Roth; Nir Hecht; Ron Rotkopf; Isam Khalaila; Eyal Gur
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-07       Impact factor: 11.205

8.  The Absence of Pupylation (Prokaryotic Ubiquitin-Like Protein Modification) Affects Morphological and Physiological Differentiation in Streptomyces coelicolor.

Authors:  Hasna Boubakri; Nicolas Seghezzi; Magalie Duchateau; Myriam Gominet; Olga Kofroňová; Oldřich Benada; Philippe Mazodier; Jean-Luc Pernodet
Journal:  J Bacteriol       Date:  2015-08-17       Impact factor: 3.490

Review 9.  Prokaryotic ubiquitin-like protein modification.

Authors:  Julie A Maupin-Furlow
Journal:  Annu Rev Microbiol       Date:  2014-05-29       Impact factor: 15.500

Review 10.  Deubiquitinating enzymes as promising drug targets for infectious diseases.

Authors:  Bindu Nanduri; Akamol E Suvarnapunya; Malabi Venkatesan; Mariola J Edelmann
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.